Researchers can minimize harm by implementing a pre-screening procedure to identify and exclude potential participants who are at a high risk for adverse reactions. This risk reduction strategy can be accomplished during the informed consent process by explicitly warning individuals about sensitive topics so they can opt out, or by collecting preliminary data through questionnaires and clinical interviews to systematically screen for physical or psychological vulnerabilities before the study begins.